Eosinophil-derived IFN-γ induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 3, 2009, Pages

  Kanda, Akira ^a,b,c,d   Driss, Virginie ^a,b,c   Hornez, Nicolas ^a,b,c   Abdallah, Marwan ^a,b,c   Roumier, Thomas ^a,b,c   Abboud, Georges ^a,b,c   Legrand, Fanny ^a,b,c   Staumont Sallé, Delphine ^a,b,c,e   Quéant, Severine ^a,b,c   Bertout, Julie ^b   Fleury, Sébastien ^a,b,c   Rémy, Patrick ^a,b,c   Papin, Jean Paul ^a,b,c   Julia, Valérie ^a,f   Capron, Monique ^a,b,c   Dombrowicz, David ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Adoptive transfer; airway hyperresponsiveness; asthma; eosinophil; IFN ; lung inflammation; severe combined immunodeficiency

Indexed keywords

COLLAGEN; EOSINOPHIL PEROXIDASE; GAMMA INTERFERON; INTERLEUKIN 5;

ADOPTIVE TRANSFER; AIRWAY HYPERRESPONSIVENESS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME RELEASE; EOSINOPHIL; LUNG FIBROSIS; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 69549138076     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.04.031     Document Type: Article

References (37)

1. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
2. Lee J.J., Dimina D., Macias M.P., Ochkur S.I., McGarry M.P., O'Neill K.R., et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305 (2004) 1773-1776
3. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., et al. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004) 1776-1779
4. Woerly G., Roger N., Loiseau S., Dombrowicz D., Capron A., and Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med 190 (1999) 487-495
5. Shi H.Z., Humbles A., Gerard C., Jin Z., and Weller P.F. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 105 (2000) 945-953
6. Leckie M.J., ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2144-2148
7. Shen H.H., Ochkur S.I., McGarry M.P., Crosby J.R., Hines E.M., Borchers M.T., et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 170 (2003) 3296-3305
8. Jacobsen E.A., Ochkur S.I., Pero R.S., Taranova A.G., Protheroe C.A., Colbert D.C., et al. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 205 (2008) 699-710
9. Walsh E.R., Sahu N., Kearley J., Benjamin E., Kang B.H., Humbles A., et al. Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med 205 (2008) 1285-1292
10. Kobayashi T., Iijima K., and Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 170 (2003) 5756-5763
11. Voehringer D., Reese T.A., Huang X., Shinkai K., and Locksley R.M. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med 203 (2006) 1435-1446
12. Rothenberg M.E., Klion A.D., Roufosse F.E., Kahn J.E., Weller P.F., Simon H.U., et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 358 (2008) 1215-1228
13. Klion A. Hypereosinophilc syndrome: current approach to diagnosis and treatment. Ann Rev Med 60 (2009) 293-306
14. O'Byrne P.M. The demise of anti IL-5 for asthma, or not. Am J Respir Crit Care Med 176 (2007) 1059-1060
15. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., and Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259 (1993) 1739-1742
16. Dent L.A., Strath M., Mellor A.L., and Sanderson C.J. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172 (1990) 1425-1431
17. Legrand F., Woerly G., Driss V., and Capron M. Innate immune function of eosinophils: from antiparasite to antitumor cells. Methods Mol Biol 415 (2008) 215-240
18. Staumont-Salle D., Abboud G., Brenuchon C., Kanda A., Roumier T., Lavogiez C., et al. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis. J Allergy Clin Immunol 121 (2008) 962-968 e6
19. Verhasselt V., Milcent V., Cazareth J., Kanda A., Fleury S., Dombrowicz D., et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med 14 (2008) 170-175
20. Kay A.B., Phipps S., and Robinson D.S. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25 (2004) 477-482
21. Bogdan C., and Schleicher U. Production of interferon-gamma by myeloid cells-fact or fancy?. Trends Immunol 27 (2006) 282-290
22. Ishihara C., Ochiai K., Kagami M., Takashahi H., Matsuyama G., Yoshida S., et al. Human peripheral eosinophils express functional interferon-gamma receptors (IFN-gammaR). Clin Exp Immunol 110 (1997) 524-529
23. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163-189
24. Salvi S., Semper A., Blomberg A., Holloway J., Jaffar Z., Papi A., et al. Interleukin-5 production by human airway epithelial cells. Am J Respir Cell Mol Biol 20 (1999) 984-991
25. Iwamoto I., Nakajima H., Endo H., and Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 177 (1993) 573-576
26. Coyle A.J., Tsuyuki S., Bertrand C., Huang S., Aguet M., Alkan S.S., et al. Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J Immunol 156 (1996) 2680-2685
27. Hofstra C.L., Van Ark I., Hofman G., Nijkamp F.P., Jardieu P.M., and Van Oosterhout A.J. Differential effects of endogenous and exogenous interferon-gamma on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 19 (1998) 826-835
28. Yoshida M., Leigh R., Matsumoto K., Wattie J., Ellis R., O'Byrne P.M., et al. Effect of interferon-gamma on allergic airway responses in interferon-gamma-deficient mice. Am J Respir Crit Care Med 166 (2002) 451-456
29. Kiwamoto T., Ishii Y., Morishima Y., Yoh K., Maeda A., Ishizaki K., et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 174 (2006) 142-151
30. Kumar R.K., Herbert C., Webb D.C., Li L., and Foster P.S. Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 170 (2004) 1043-1048
31. Heaton T., Rowe J., Turner S., Aalberse R.C., de Klerk N., Suriyaarachchi D., et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365 (2005) 142-149
32. Hayashi N., Yoshimoto T., Izuhara K., Matsui K., Tanaka T., and Nakanishi K. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production. Proc Natl Acad Sci U S A 104 (2007) 14765-14770
33. Fischer R., Tome D., McGhee J.R., and Boyaka P.N. Th1 and Th2 cells are required for both eosinophil- and neutrophil-associated airway inflammatory responses in mice. Biochem Biophys Res Commun 357 (2007) 44-49
34. Kelchtermans H., Billiau A., and Matthys P. How interferon-gamma keeps autoimmune diseases in check. Trends Immunol 29 (2008) 479-486
35. Ochiai K., Tanabe E., Ishihara C., Kagami M., Sugiyama T., Sueishi M., et al. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 118 (1999) 340-343
36. Valerius T., Repp R., Kalden J.R., and Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol 145 (1990) 2950-2958
37. Bernabei P., Coccia E.M., Rigamonti L., Bosticardo M., Forni G., Pestka S., et al. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leukoc Biol 70 (2001) 950-960